Tag: Clinical trial News
Model explaining how the brain obtains needed omega-3 fatty acids is created by researchers.
A zebrafish model created by National Institutes of Health (NIH) researchers and associates sheds new light on how…
Indian healthcare attributes the success of transplants to improved organ preservation and anti-rejection medications.
The success of organ transplants in India is credited to improved organ preservation techniques, cutting-edge surgery, and anti-rejection…
DCGI launches an investigation into antipsychotic drugs made without authorization.
In its most recent meeting, the National Pharmaceutical Pricing Authority (NPPA) set a ceiling price for the antipsychotic…
AiMeD appreciates the National Medical Devices Policy 2023’s cabinet approval.
The Central Government’s decision to approve the much-needed National Medical Devices Policy (NMDP), 2023, has been applauded by…
In order to better manage the rare disease Myasthenia gravis, UCB and Huma have partnered to develop digital health solutions.
With the support of their physician, patients with the uncommon disease Myasthenia gravis (MG) can better understand and…
The UK MHRA has approved the chemotherapeutic medication Cisplatin from Venus Remedies for marketing.
Cisplatin, a chemotherapy drug used as a first-line treatment for advanced ovarian cancer, testicular cancer, and bladder carcinoma,…
To evaluate the PEF rate of lung function in asthma patients, Tenovi develops a cellular remote Peak Flow Metre that has been approved by the US FDA.
Tenovi offers Tenovi, a leader in US FDA-approved remote patient monitoring (RPM) solutions, recently announced the release of…
Sulbactam-durlobactam from Innoviva should be approved by the US FDA to treat ventilator-associated bacterial pneumonia and hospital-acquired bacterial pneumonia.
The US Food and Drug Administration’s (FDA) Antimicrobial Drugs Advisory Committee (AMDAC) unanimously voted 12-0 in favour of…
For Medicare users, Abbott’s FreeStyle Libre continuous glucose monitoring systems receive significantly greater coverage.
Abbott’s FreeStyle Libre portfolio, the most widely used and reasonably priced continuous glucose monitoring system (CGM) in the…
In persons with certain forms of adjuvant liver cancer, Roche reports that the Tecentriq + Avastin phase III IMbrave050 research lowers the likelihood of the cancer coming back.
Avastin (bevacizumab) plus Tecentriq (atezolizumab) showed a statistically significant improvement in recurrence-free survival (RFS) in patients with hepatocellular…
Registration Form
This will close in 0 seconds
